AI-Designed drug targets scarred lungs in major trial
NCT ID NCT07687459
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether the oral drug rentosertib (INS018_055) can slow lung function decline in adults with idiopathic pulmonary fibrosis (IPF), a progressive lung disease. About 320 participants will receive either rentosertib or a placebo daily for 52 weeks. The main goal is to measure changes in forced vital capacity, a key indicator of lung health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- rentosertib (INS018_055)
- What this could lead to
- If successful, rentosertib could slow lung function decline in people with idiopathic pulmonary fibrosis, offering a new treatment option for this serious disease.
- What could go wrong
- This is a phase 3 trial, but results may not show benefit over placebo. The drug could have side effects, and its long-term safety is still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hangzhou First People's Hospital,School of Medicine, Westlake University
Hangzhou, Zhejiang, China
-
Anhui Chest Hospital
Hefei, Anhui, China
-
Anhui Provincial Hospital
Hefei, Anhui, China
-
Beijing Chaoyang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
Fuzhou University Affiliated Provincial Hospital
Fuzhou, Fujian, China
-
Hainan General Hospital
Haikou, Hainan, China
-
Hebei Medical University Third Hospital
Shijiazhuang, Hebei, China
-
Henan Provincial People's Hospital
Zhengzhou, Henan, China
-
Introduction of the First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, China
-
Jiangxi Provincial People' Hospital
Nanchang, Jiangxi, China
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
-
Nanyang First People's Hospital
Nanyang, Henan, China
-
Ningbo Medical Center Lihuili Hospital
Ningbo, Zhejiang, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, China
-
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
-
Shanghai Pulmonary Hospital Affiliated to Tongji University
Shanghai, Shanghai Municipality, China
-
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
-
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
-
Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
-
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
-
The First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, China
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
-
The First Affiliated Hospital of Xi'an Medical College
Xi'an, Shaanxi, China
-
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
The First Hospital of Jiaxing
Jiaxing, Zhejiang, China
-
The First People Hospital of Yunnan Province
Kunming, Yunnan, China
-
The People's Hospital of Anyang City
Anyang, Henan, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
-
The Second Affiliated Hospital of Xiamen Medical College
Xiamen, Fujian, China
-
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
-
The Second Hospital of Jilin University
Changchun, Jilin, China
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
-
The Xiangya Hospital of Central South University
Changsha, Hunan, China
-
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, China
-
Yichang Central People's Hospital
Yichang, Hubei, China
-
Yuncheng Central Hospital
Yuncheng, Shanxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
- AI outruns radiologists in detecting early lung scarring
- Experimental drug aims to slow lung scarring in IPF
- Can scans replace breathing tests to monitor lung scarring?
- New drug candidate SCB0020160 enters first human safety tests